This suggests that IGF-1 could be both a pro-atherogenic and an anti-atherogenic factor [38] indicating that IGFBP-3 levels and its regulation on IGF-1 may be a better indicator and marker of insulin resistance. The gene discussed is IGF1; the disease is Insulin resistance.